Dr. Albelda is one of the world’s most respected experts in the field of thoracic oncology. He is the William Maul Measey Professor of Medicine at the Perelman School of Medicine and Associate Director of the Pulmonary Division, Director of the Thoracic Oncology Research Laboratory, and co-Director of the Translational Center of Excellence for Lung
Dr. Keith Cengel is a board-certified radiation oncologist practicing in Philadelphia, Pennsylvania. He is the Executive Director of the Mesothelioma and Pleural Diseases Program and a Penn Medicine physician. As Director of the Photodynamic Therapy Program, he has special expertise in the use of advanced radiation therapy protocols to treat malignant mesothelioma. Education and Career
Dr. Lambright is a general thoracic surgeon with special interests in pulmonary malignancies, including malignant mesothelioma. He has conducted extensive research in novel therapies for chest malignancies, including cancer gene therapies. In addition to his work at Vanderbilt, he is Chief of Thoracic Surgery at Nashville Veterans’ Affairs Hospital. Education and Career Born in Adidome, Ghana,
Unlike the United States, many countries in Europe and across the world have banned the use of asbestos in order to lower the risk of malignant mesothelioma and other asbestos-related diseases. But the continued presence of asbestos in already-built structures continues to pose a threat, and together with the European Parliament, the Council of the
Barbara Bobo died of malignant mesothelioma on the 16th anniversary of her husband’s death from lung cancer induced by asbestosis. Before her death she filed a personal injury lawsuit against her late husband’s employer, the Tennessee Valley Authority, accusing them of negligently exposing her to asbestos carried home on her husband’s work clothing. When her daughters
Clinical trials are essential to finding the best treatments – and potentially a cure – for malignant mesothelioma. But for these research studies to accurately indicate the efficacy of a protocol, clinical trial participant demographics must reflect actual patient populations. A recent study indicated that when it comes to precision cancer studies, minorities may be
Despite exposure to asbestos leading to malignant mesothelioma, lung cancer, asbestosis, and other serious and deadly diseases, lobbying efforts by the chemical industry have led to its continued use in the United States. While the EPA considers banning its use, anti-asbestos advocates are taking matters into their own hands: they have announced a day of
For years, Akron’s tire and rubber company workers have been diagnosed with a variety of asbestos-related diseases, including malignant mesothelioma, asbestos-related lung cancer, and asbestosis. They traced their illnesses back to multiple sources, including asbestos-contaminated talc that rubber companies used to keep the rubber from sticking to other rubber, or to their equipment. Following years
Mesothelioma researchers continue to search for the best approach to the rare, asbestos-related disease. A recent report indicated that immune checkpoint inhibitors can have a positive impact when administered with chemotherapy prior to surgery.
Many mesothelioma victims pursue litigation against the asbestos companies that exposed them to the toxic material. Most name multiple defendants whose products contained asbestos or who supplied the carcinogen. When plaintiffs win, the jury apportions the amount of compensation each defendant must pay based on numerous factors. But a decision made in 2020 by the